Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CATX | Perspective Therapeutics, Inc.

Index- P/E- EPS (ttm)-0.09 Insider Own0.20% Shs Outstand279.99M Perf Week-19.89%
Market Cap145.17M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float217.83M Perf Month-23.33%
Income-18.80M PEG- EPS next Q-0.04 Inst Own11.30% Short Float / Ratio0.72% / 1.62 Perf Quarter-55.88%
Sales7.70M P/S18.85 EPS this Y-0.80% Inst Trans-1.27% Short Interest1.57M Perf Half Y-55.44%
Book/sh0.39 P/B0.77 EPS next Y- ROA-20.40% Target Price1.20 Perf Year-11.63%
Cash/sh0.06 P/C5.13 EPS next 5Y- ROE-22.20% 52W Range0.19 - 0.73 Perf YTD21.41%
Dividend- P/FCF- EPS past 5Y15.80% ROI-14.50% 52W High-58.89% Beta1.65
Dividend %- Quick Ratio3.60 Sales past 5Y-9.70% Gross Margin20.10% 52W Low56.09% ATR0.06
Employees88 Current Ratio3.70 Sales Q/Q-16.00% Oper. Margin- RSI (14)38.21 Volatility48.77% 16.15%
OptionableNo Debt/Eq0.02 EPS Q/Q-171.20% Profit Margin- Rel Volume1.18 Prev Close0.29
ShortableYes LT Debt/Eq0.02 EarningsAug 11 BMO Payout- Avg Volume969.46K Price0.30
Recom1.00 SMA20-19.49% SMA50-37.07% SMA200-37.80% Volume1,143,182 Change5.04%
Sep-12-23 08:00AM
Sep-11-23 08:00AM
Aug-30-23 08:17AM
Aug-28-23 08:00AM
Aug-11-23 09:15AM
08:11AM Loading…
Aug-09-23 08:05AM
Jun-27-23 08:00AM
Jun-21-23 08:00AM
Jun-16-23 08:00AM
Jun-08-23 08:00AM
May-28-23 06:36PM
May-24-23 08:10AM
05:02AM Loading…
May-16-23 05:02AM
May-15-23 08:22PM
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.